Mutia, Fernanda .

HRN: 20-20-30  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/18/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/18/2026
03/25/2026
IV
2.25G
Q8H
Pneumonia
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: